试管LAI测定在肿瘤疾病诊断和监测中的应用。

Biomedicine / [publiee pour l'A.A.I.C.I.G.] Pub Date : 1981-12-01

M Hasek, V Holán, M Kousalová

{"title":"试管LAI测定在肿瘤疾病诊断和监测中的应用。","authors":"M Hasek, V Holán, M Kousalová","doi":"","DOIUrl":null,"url":null,"abstract":"The tube leukocyte adherence inhibition (LAI) assay was used to follow the specific antitumor immunity in patients with tumors of the urogenital tract, carcinomas of the larynx, melanomas and lung tumors. Positive reactivity was observed in more than 80% of the patients with tumor, whereas less than 5% of the controls were positive. The results show that the tube LAI assay holds promise for diagnosing and monitoring cancer diseases.","PeriodicalId":9217,"journal":{"name":"Biomedicine / [publiee pour l'A.A.I.C.I.G.]","volume":"35 7-8","pages":"207-8"},"PeriodicalIF":0.0000,"publicationDate":"1981-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Tube LAI assay in diagnosis and monitoring of a cancer disease.\",\"authors\":\"M Hasek, V Holán, M Kousalová\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The tube leukocyte adherence inhibition (LAI) assay was used to follow the specific antitumor immunity in patients with tumors of the urogenital tract, carcinomas of the larynx, melanomas and lung tumors. Positive reactivity was observed in more than 80% of the patients with tumor, whereas less than 5% of the controls were positive. The results show that the tube LAI assay holds promise for diagnosing and monitoring cancer diseases.\",\"PeriodicalId\":9217,\"journal\":{\"name\":\"Biomedicine / [publiee pour l'A.A.I.C.I.G.]\",\"volume\":\"35 7-8\",\"pages\":\"207-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1981-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomedicine / [publiee pour l'A.A.I.C.I.G.]\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedicine / [publiee pour l'A.A.I.C.I.G.]","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

采用白细胞粘附抑制(LAI)法观察泌尿生殖道肿瘤、喉癌、黑色素瘤和肺癌患者的特异性抗肿瘤免疫反应。在80%以上的肿瘤患者中观察到阳性反应，而对照组的阳性反应不到5%。结果表明，试管LAI测定在诊断和监测癌症疾病方面具有前景。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Tube LAI assay in diagnosis and monitoring of a cancer disease.

The tube leukocyte adherence inhibition (LAI) assay was used to follow the specific antitumor immunity in patients with tumors of the urogenital tract, carcinomas of the larynx, melanomas and lung tumors. Positive reactivity was observed in more than 80% of the patients with tumor, whereas less than 5% of the controls were positive. The results show that the tube LAI assay holds promise for diagnosing and monitoring cancer diseases.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Biomedicine / [publiee pour l'A.A.I.C.I.G.]

自引率

0.00%

发文量